Plant Systems and Synthetic Biology
The study of interactions among biological components using models and/or networks to integrate genes, metabolites, proteins, regulatory elements, and other biological components is known as plant systems biology. Postgenomic omics technologies such as microarrays for high-throughput collection of large-scale data are linked but not synonymous with systems biology.
Synthetic biology is a branch of research that entails reengineering organisms in order to remodel them for beneficial purposes. Researchers and organizations all across the world are using synthetic biology to solve challenges in medical, manufacturing, and agriculture. Synthetic biology initiatives often aim to redesign organisms so that they generate a substance, such as a medicine or fuel, or develop a new ability, such as sensing something in the environment.
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States